Medi Assist Healthcare Services Ltd Share Price – NSE /  BSE

Miscellaneous, Small Cap

Medi Assist Healthcare Services announced the integration of UIDAI's Aadhaar Offline Verification Framework into its health benefits platforms after becoming a registered Offline Verification Seeking Entity (OVSE). The integration enables secure, consent-based identity verification across key healthcare journeys, helping members access their health benefits with reduced paperwork while lowering the risk of identity misuse, impersonation, and document-related fraud.

Built on UIDAI's Aadhaar Offline Verification Framework, the capability allows members to verify their identity quickly and securely, with explicit consent and by sharing only the information required for a specific transaction. By reducing reliance on photocopies or physical identity documents, the process helps safeguard member privacy while making verification simpler and more reliable. Location information captured during verification also helps confirm that the healthcare interaction is genuine, giving members greater confidence that their health benefits are accessed only by the rightful beneficiary.

For insurers and employers, the capability strengthens identity assurance, reduces manual documentation, supports faster claims processing, and helps create a more trusted healthcare benefits ecosystem.

The Aadhaar Offline Verification capability will be made available to TPAs, insurers, and pension funds that leverage Medi Assist's technology platforms, extending the benefits of secure, consent-based identity verification across a wider health benefits ecosystem. 

The stock has gained 5.21% in two sessions after the company on 9 May 2026 reported a sharp rise in quarterly profit aided by higher revenue and lower finance costs. The stock had risen 1.95% in the previous session.

Consolidated profit after tax stood at Rs 53.44 crore in Q4 FY26, up 148.10% from Rs 21.54 crore in Q4 FY25 and surged 448.67% from Rs 9.74 crore in Q3 FY26.

Revenue from operations increased 28.13% YoY to Rs 241.99 crore in Q4 FY26. It rose 0.96% sequentially from Rs 239.68 crore in Q3 FY26.

Profit before tax stood at Rs 27.90 crore in Q4 FY26 compared with Rs 30 crore in Q4 FY25, down 7% YoY. On a sequential basis, PBT surged 229.40% from Rs 8.47 crore in Q3 FY26.

EBITDA margin improved to 19.9% in Q4 FY26 from 18.6% in Q3 FY26 and 17.1% in Q2 FY26.

On the cost front, total expenditure rose 30.75% YoY to Rs 193.73 crore in Q4 FY26. Employee expenses increased 33.53% to Rs 105.38 crore from Rs 78.92 crore.

Interest cost declined 85.09% YoY to Rs 0.65 crore from Rs 4.36 crore, while depreciation expense rose 48.48% to Rs 20.95 crore from Rs 14.11 crore.

For FY26, revenue from operations increased 25.09% YoY to Rs 904.77 crore, with the TPA business contributing growth of 25.5% and new lines of business delivering 30.7% growth.

Full-year profit before tax declined 28.07% to Rs 80.35 crore from Rs 111.70 crore in FY25, while profit after tax fell 3.29% to Rs 87.89 crore from Rs 90.88 crore.

Net cash from operating activities declined to Rs 118.07 crore in FY26 from Rs 138.09 crore in FY25.

The company reported a free cash position of Rs 260.5 crore as of FY26 against Rs 312.2 crore in FY25. Net worth increased to Rs 852.4 crore from Rs 552.2 crore a year earlier.

Medi Assist became debt-free from January 2026 onwards compared with debt of Rs 150.1 crore in FY25.

Total Group plus Retail premiums administered grew 22.8% YoY to Rs 25,923.2 crore in FY26. The share of Group plus Retail premiums under administration increased 115 bps YoY to 20.7%, while group market share expanded 340 bps to 33.7%.

During FY26, the company processed 100.3 lakh claims excluding SaaS utilisation, comprising 21.6 lakh cashless inpatient claims, 12.9 lakh reimbursement inpatient claims, 27.5 lakh cashless outpatient claims and 38.3 lakh reimbursement outpatient claims.

Satish Gidugu, CEO of Medi Assist, said the company combined strong growth with technology-led transformation during FY26 and added that its AI-powered platforms are processing nearly one million claims every month.

Medi Assist Healthcare Services provides health benefits administration and technology solutions to the health insurance ecosystem. Through its subsidiaries, the company facilitates claims and healthcare administration services for insurers, policyholders, hospitals, corporates, global insurers and government health schemes.

Powered by Capital Market - Live News

Net sales for the period under review rose by 28.1% YoY to Rs 241.99 crore.

Total operating expenses increased by 30.7% to Rs 193.73 crore in Q4 FY26 over Q4 FY25.

Profit before tax in Q4 FY26 stood at Rs 27.90 crore, down by 7% from Rs 30 crore in Q4 FY25. Tax outgo for the March 2026 quarter was Rs 4.93 crore, down 36.6% YoY. The company wrote back deferred taxes worth Rs 31.50 crore in Q4 FY26.

For FY26, the company has recorded net profit and revenue from operations of Rs 87.89 crore (down 3.3% YoY) and Rs 904.77 crore (up 25.1% YoY), respectively.

Satish Gidugu, chief executive officer and whole-time director, said: FY26 was a milestone year for Medi Assist as we combined strong growth with deep technology-led transformation.

Becoming debt-free and net-cash-positive strengthens our ability to invest in the future, while our AI-powered platforms are now operating at unprecedented scale, processing nearly one million claims every month with industry-leading automation and fraud detection.

The rapid expansion of MAtrix, successful integration of Paramount, and our new global partnerships position us strongly to build the next generation of intelligent, borderless healthcare administration.

Medi Assist provides health benefits administration services through its subsidiaries, Medi Assist TPA and Paramount Health Services, connecting insurers, hospitals, corporates, and government health schemes.

Powered by Capital Market - Live News

Medi Assist Healthcare Services announced that the Board of Directors of the Company at its meeting held on 9 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.